ESCMID
CMI
EUCAST Newsletter
EUCAST News
Search
Back
Close
About EUCAST
About EUCAST
Overview
Close
Organisation
Overview
Steering Committee
General Committee
EUCAST Statutes
National AST Committees (NAC)
Network Laboratories
Development Laboratories (EDL)
View all
Subcommittees
Overview
Antimycobacterial Susceptibility Testing (AMST)
Antifungal Susceptibility Testing (AFST)
Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST)
Phage Susceptibility Testing Subcommittee (PST)
Subcommittee on WGS and Phenotypic AST
View all
Meetings
Overview
Steering Committee Meetings
General Committee Meetings
Public Consultations
Overview
SOPs
Overview
IVDR and EUCAST
Overview
News
Overview
Publications and Presentations
Overview
Bacteria
Bacteria
Overview
Close
Clinical Breakpoints and Interpretation
Overview
Clinical Breakpoint Tables
Definition of S, I and R
When there are no breakpoints?
Breakpoints in Brackets
Guidance Documents
Overview
Important Additional Information
Overview
Expert Rules
Expected Phenotypes
Resistance Detection
MIC and Zone Distributions, ECOFFs
Overview
Methodology and Instructions
Overview
Disk Diffusion and Quality Control
MIC Determination
Warnings
Media Preparation
Disk Diffusion Implementation
EUCAST Panels of Phenotypically Defined Strains
Overview
EUCAST Panel of S. pneumoniae and betalactam agents
EUCAST Panel of nine well characterized P. aeruginosa strains
IVDR and EUCAST
View all
Rapid AST in blood culture
Overview
Rapid AST directly from blood culture bottles
Methods and Quality Control
Breakpoints for Rapid AST
Resistance Detection in RAST
RAST FAQ
RAST MIC:zone diameter correlations
RAST Publications
View all
Development of Clinical Breakpoints and ECOFFs
Overview
About Clinical Breakpoints
Setting Breakpoints
Public Consultations
Rationale Documents
MIC:Zone Diameter correlations
Technical Notes on Antibacterial Agents
View all
FAQ and EDL Services
Overview
FAQ
EDL MIC Testing Services
Mycobacteria (AMST)
Mycobacteria (AMST)
Overview
Close
Subcommittee
Overview
Clinical Breakpoints and Interpretation
Overview
MIC distributions and ECOFFs
Overview
Development of Clinical Breakpoints and ECOFFs
Overview
Public Consultations
Rationale Documents
Methodology and Instructions
Overview
Reference Method
Mycobacteria FAQ
Warnings
IVDR and EUCAST
Publications and Presentations
Overview
Fungi (AFST)
Fungi (AFST)
Overview
Close
Subcommittee
Overview
Clinical Breakpoints and Interpretation
Overview
Clinical breakpoint table
When there are no antifungal breakpoints
Development of clinical breakpoints and ECOFFs
Overview
Rationale documents
Public consultations
Methodology and Instructions
Overview
AST of Yeasts
AST of Moulds
AST of Dermatophytes
Warnings
Quality Control
IVDR and EUCAST
View all
Publications and Presentations
Overview
Technical Notes on Antifungal Agents
VetCAST
VetCAST
Overview
Close
Subcommittee
Overview
MIC distributions and ECOFFs
Overview
Development of clinical breakpoints and ECOFFs
Overview
Rationale Documents
Publications and presentations
Overview
Industry
Industry
Overview
Close
Education
Education
Overview
Close
Search
ESCMID
CMI
EUCAST Newsletter
EUCAST News
Close
Search
Frequent searches
breakpoints
rationale documents
expected phenotypes
public consultation
endocarditis pathogens
guidance documents
Suggestions
Close
Fungi (AFST)
Document Archive
Document Archive
Breakpoint tables for fungi
QC tables
Methodology
Rationale documents
Clinical breakpoints for fungi (v 11.0)
- pdf file for printing (until 26 June, 2025)
Clinical breakpoints for fungi (v 11.0)
- excel file for screen (until 26 June, 2025)
Clinical breakpoints for fungi (v 10.0)
- pdf file for printing (until 2 December, 2024)
Clinical breakpoints for fungi (v 10.0)
- excel file for screen (until 2 December, 2024)
Clinical breakpoints - fungi (v 9.0)
- pdf file for printing (until 4 February, 2020)
Clinical breakpoints - fungi (v 9.0)
- excel file for screen (until 4 February, 2020)
Clinical breakpoints - fungi (v 8.1)
- pdf file for printing (until 11 February, 2018)
Clinical breakpoints - fungi (v 8.1)
- excel file for screen (until 11 February, 2018)
Clinical breakpoints - fungi (v 7.0)
- pdf file for printing (until 15 November, 2015)
Clinical breakpoints - fungi (v 7.0)
- excel file for screen (until 15 November, 2015)
Clinical breakpoints - fungi (v 6.1)
- pdf file for printing (until 12 August, 2014)
Clinical breakpoints - fungi (v 6.1
) - excel file for screen (until 12 August, 2014)
Clinical breakpoints - fungi (v 6.0)
- pdf file for printing (until March 11, 2013)
Clinical breakpoints - fungi (v 6.0)
- excel file for screen (until March 11, 2013)
Clinical breakpoints - fungi (v 5.0)
- Excel file for screen (until March 1, 2013)
Clinical breakpoints - fungi (v 5.0)
- pdf file for printing (until March 1, 2013)
Clinical breakpoints - fungi (v 4.1)
- (until Jan 9, 2013) - for screen
Clinical breakpoints - fungi (v 4.1)
- (until Jan 9, 2013) - for printing
Clinical breakpoints - fungi (v 3.0) - (contact the EUCAST webmaster)
Overview of antifungal ECOFFs and clinical breakpoints for yeasts and moulds
- valid from 2 December, 2024;
Previous version
valid from 14 August, 2023;
Previous version
valid from 18 January 2022;
Previous version
valid from 24 September, 2020.
QC AFST Tables v 6.0
(2022-05-04)
QC AFST Tables v 5.0
(2020-09-24)
QC AFST Tables v 4.0
(2020-02-04)
QC AFST Tables v 3.0
(2019-04-04)
QC AFST Tables v 2.0
(2018-06-29)
QC AFST Tables v 1.0
(2015-11-04)
EUCAST method for susceptibility testing of yeasts
(v. 7.3.2 until 13 October, 2023)
EUCAST E.Def 10.1 Screening method for the detection of azole resistance in A. fumigatus
(until June 2022)
EUCAST method for susceptibility testing of moulds
(v. 9.3.2 until March 2022)
EUCAST method for susceptibility testing of yeasts
(v. 7.3.1 until 22 April 2020)
EUCAST method for susceptibility testing of moulds
(v. 9.3.1 until 22 April, 2020)
EUCAST method for susceptibility testing of yeasts
(v. 7.3 until 15 January, 2017)
EUCAST method for susceptibility testing of moulds
(v. 9.3 until 15 January, 2017)
EUCAST method for susceptibility testing of moulds
(v. 9.2 until 22 December, 2015)
EUCAST method for susceptibility testing of moulds
(v. 9.1 until 25 August, 2014) and the corresponding
Technical notes
Amphotericin B
v 2.0 (2020)
Amphotericin B vs. Candida
v 1.0
Amphotericin B vs. Aspergillus
v 1.0
Anidulafungin vs. Candida
v 4.0 (25 November, 2024)
Anidulafungin vs. Candida
v 3.0 (2020);
Anidulafungin vs. Candida
v 2.0 (
comments during consultation
)
Fluconazole vs. Candida
v 2.0 (
comments during consultation
) - 2018
Isavuconazole vs. Aspergillus
v 1.0
Isavuconazole vs. Aspergillus
v 2.0 (2020)
Itraconazole vs. Aspergillus
v 1.1 (
comments during consultation
)
Micafungin vs. Candida
v 3.0 (25 November, 2024)
Micafungin vs. Candida
v 2.0 (2020);
Micafungin vs. Candida
v 1.0 (
comments during consultation
)
Posaconazole
v 2.0 (this document constitutes a merge and update of previous individual documents:
Posaconazole vs. Candida
v 1.0
Posaconazole vs. Aspergillus
v 1.0).
Rezafungin
v 1.0 (2024)
Voriconazole
v 3.0 (19 Dec 2017) (this constitutes a merge and update of previous individual documents:
Voriconazole vs. Candida
v 2.0 and
Voriconazole vs. Aspergillus
v 1.0).
Itraconazole vs. Aspergillus
v 2.0 (2020) and
Itraconazole vs. Candida
v 1.0 - amalgamated 2021 in RD itraconazole v 3.0
Contact
Looking for more information? Get in touch with an EUCAST representative today!
Contact form